pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Type and number of medications associated with pharmacist’s intervention (n=584)

Type of medications Number (%)
Antineoplastic agents 90(15.4%)
Antimicrobial agents 165(28.3%)
Antibacterials for systemic use 65(11.1%)
Antivirals for systemic use 63(10.8%)
Antimycotics for systemic use 32(5.5%)
Antimycobacterials 5(0.9%)

Supportive care agents 187(32.0%)
Corticosteroids for systemic use 44(7.5%)
Blood substitutes and perfusion solutions 40(6.8%)
Drugs for acid related disorders 24(4.1%)
Immunostimulants 16(2.7%)
Antiepileptics 15(2.6%)
Immunosuppressants 14(2.4%)
Antiemetics and antinauseants 13(2.2%)
Endocrine therapy 13(2.2%)
Antigout preparations 7(1.2%)
Immune sera and immunoglobulins 1(0.2%)

Other agents* 142(24.3%)

*Psycholeptics, drugs for constipation, antidiarrheals, intestinal antiinflammatory/antiinfective agents, drugs for functional gastrointestinal disorders, lipid modifying agents, drugs used in diabetes, calcium channel blockers, analgesics, diuretics, mineral supplements, antianemic preparations, bile and liver therapy, vitamins, urologicals, antithrom-botic agents, other nervous system drugs, antihistamines for systemic use, antihemorrhagics, general nutrients, vasoprotectives, throat preparations, ophthalmologicals, nasal preparations, digestives, incl. enzymes, cough and cold preparations, cardiac therapy, anti-parkinson drugs, anti-inflammatory and antirheumatic products, antifungals for dermatological use, agents acting on the reninangiotensin system

Korean J Clin Pharm 2022;32:215-25 https://doi.org/10.24304/kjcp.2022.32.3.215
© 2022 Korean J Clin Pharm